KC-4552

CHOK1-Tet-on-MAPT-P301L-low Cell Line

×
Please enable JavaScript in your browser to complete this form.
61206
Home » CHOK1-Tet-on-MAPT-P301L-low Cell Line

Background of CHOK1-Tet-on-MAPT-P301L-low Cell Line

MAPT (Microtubule Associated Protein Tau) is a Protein Coding gene. This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.

Specifications

Catalog NumberKC-4552
Cell Line NameCHOK1-Tet-on-MAPT-P301L-low Cell Line
NCBI/UniProt Accession NumberNM_005910.6
Clone Number2#
Host Cell LineCHOK1
DescriptionCHOK1 cell line stably expressing exogenous MAPT-P301L gene, The gene is under the control of a tet-on inducible system.
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI1640 + 20% FBS + 10% DMSO
Propagation MediumRPMI1640 + 10% FBS + 10 μg/mL Puromycin
Selection MarkerPuromycin
MorphologyEpithelial
SubcultureSplit saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 30 hours
Mycoplasma StatusNegative

Cell Line Generation

CHOK1-Tet-on-MAPT-P301L-low cell line was generated using a lentiviral vector expressing the MAPT-P301L sequence, MAPT-P301L gene is under the control of a tet-on inducible system.

Characterization

Figure1: Characterization of MAPT-P301L overexpressing in CHOK1 stable clones using WB (clone 2#).

Figure2: Characterization of CHOK1-Tet-on-MAPT-P301L-low cell line stable clone using PCR sequencing (clone 2#).

Cell Resuscitation

  1. Prewarm culture medium (RPMI1640 + 10% FBS + 10 μg/mL Puromycin) in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% RPMI1640 + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage.

References

  1. Basurto-Islas G, Luna-Muñoz J, Guillozet-Bongaarts AL, Binder LI, Mena R, García-Sierra F. Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. J Neuropathol Exp Neurol. 2008 May;67(5):470-83. doi: 10.1097/NEN.0b013e31817275c7. PMID: 18431250; PMCID: PMC4699801.
  2. Djukic M, Spreer A, Lange P, Bunkowski S, Wiltfang J, Nau R. Small cisterno-lumbar gradient of phosphorylated Tau protein in geriatric patients with suspected normal pressure hydrocephalus. Fluids Barriers CNS. 2016 Aug 31;13(1):15. doi: 10.1186/s12987-016-0039-9. PMID: 27581842; PMCID: PMC5007695.
  3. Silva MC, Cheng C, Mair W, Almeida S, Fong H, Biswas MHU, Zhang Z, Huang Y, Temple S, Coppola G, Geschwind DH, Karydas A, Miller BL, Kosik KS, Gao FB, Steen JA, Haggarty SJ. Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability. Stem Cell Reports. 2016 Sep 13;7(3):325-340. doi: 10.1016/j.stemcr.2016.08.001. Epub 2016 Sep 1. PMID: 27594585; PMCID: PMC5032560.
Please enable JavaScript in your browser to complete this form.